The relation between nailfold bleeding and capillary microscopic abnormality in pateints with connective tissue diseases

International Journal of Dermatology

Volumn 37, Issue 1, 1998, Pages 23-26

  Ohtsuka, Tsutomu ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CAPILLARY RESISTANCE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NAIL DISEASE; RAYNAUD PHENOMENON; SCLERODERMA; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPILLARIES; CONNECTIVE TISSUE DISEASES; FEMALE; HEMORRHAGE; HUMANS; JAPAN; MALE; MICROCIRCULATION; MICROSCOPY; MIDDLE AGED; NAIL DISEASES; NAILS; PREVALENCE; RAYNAUD DISEASE;

EID: 0031919096     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00313.x     Document Type: Article

References (19)

1. Ohtsuka T, Ishikawa H. Statistical definition of nail fold capillary patterns in patients with systemic sclerosis. Dermatology 1994; 188: 286-289.
2. Maricq HR. Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24: 1159-1165.
3. Sato S, Takehara K, Soma Y, et al. Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders. J Am Acad Dermatol 1993; 28: 198-203.
4. Subcommittee for Scleroderma Critieria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
6. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
7. Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease - an apparently distinct rheumatic-disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-159.
8. Daniels TE, Talal N. Diagnosis and differential diagnosis of Sjögren's syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, eds. Sjögren's Syndrome: Clinical and Immunological Aspects. Berlin: Springer-Verlag, 1987.
9. Arnett FC, Edworthy SM, Bloch DA, et al. The American Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
10. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
11. Frederiksson T, Peterson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
12. Maricq HR, LeRoy EC, D'Angelo WA, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23: 183-189.
13. Lee P, Sarkozi J, Bookman AA, et al. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon. J Rheumatol 1986; 13: 564-569.
14. Takehara K, Soma Y, Ishibashi Y. Early detection of scleroderma spectrum disorders in patients with Raynaud's phenomenon. Dermatologica 1991; 183: 164-168.
15. Maricq HR. The microcirculation in scleroderma and allied diseases. Adv Microcirc 1982; 10: 17-52.
16. Maricq HR, Weinrich MC, Keil JE et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989; 32: 998-1006.
17. Ohtsuka T, Yamakage A, Tamura T. Image analysis of nailfold capillaries in patients with Raynaud's phenomenon. Cutis 1995; 56: 215-218.
18. Ohtsuka T, Yamakage A, Tamura T. Image analysis of nailfold capillaries in patients with undifferentiated connective tissue syndrome. J Dermatol 1995; 22: 921-925.
19. Maricq HR, Harper FE, Khan MM, et al. Microvascular abnormalities as possible predictors of disease subsets in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195-205.